Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE NON-CONTROLLING INTERESTS AND STOCKHOLDERS??? EQUITY

v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE NON-CONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Non-controlling Interests (“NCI”)
Redeemable non-controlling interests, beginning balance at Dec. 31, 2023 $ 46,865                  
Redeemable Non-controlling Interests (“RNCI”)                    
Distributions to RNCI (418)                  
Accretion of tax equity financing fees 80                  
Net (loss) income (3,766)                  
Redeemable non-controlling interests, ending balance at Sep. 30, 2024 42,761                  
Beginning balance (in shares) at Dec. 31, 2023       34,277,195 18,000,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2023                 2,101,795  
Beginning balance at Dec. 31, 2023 925,886     $ 3 $ 2 $ 320,892 $ 595,911 $ (3,045) $ (11,788) $ 23,911
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       70,089            
Exercise of stock options 909         909        
Stock-based compensation expense 10,368         10,368        
Employee stock purchase plan (in shares)       32,841            
Employee stock purchase plan 990         990        
Restricted stock units released (in shares)       62,626         40  
Unrealized loss from interest rate hedges, net (446)             (446)    
Foreign currency translation adjustment 652             688   (36)
Accretion of tax equity financing fees (80)           (80)      
Contributions from NCI 33,789         3,040       30,749
Distributions to NCI (1,367)                 (1,367)
Purchase of shares from NCI (23,760)         226       (23,986)
Net (loss) income 19,796           19,672     124
Ending balance (in shares) at Sep. 30, 2024       34,442,751 18,000,000          
Treasury stock, ending balance (in shares) at Sep. 30, 2024                 2,101,835  
Ending balance at Sep. 30, 2024 966,737     $ 3 $ 2 336,425 615,503 (2,803) $ (11,788) 29,395
Redeemable non-controlling interests, beginning balance at Jun. 30, 2024 43,777                  
Redeemable Non-controlling Interests (“RNCI”)                    
Distributions to RNCI (130)                  
Accretion of tax equity financing fees 26                  
Net (loss) income (912)                  
Redeemable non-controlling interests, ending balance at Sep. 30, 2024 42,761                  
Beginning balance (in shares) at Jun. 30, 2024       34,402,515 18,000,000          
Treasury stock, beginning balance (in shares) at Jun. 30, 2024                 2,101,795  
Beginning balance at Jun. 30, 2024 941,192     $ 3 $ 2 332,356 597,930 (3,800) $ (11,788) 26,489
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       7,500            
Exercise of stock options 405         405        
Stock-based compensation expense 3,664         3,664        
Restricted stock units released (in shares)       32,736         40  
Unrealized loss from interest rate hedges, net (1,060)             (1,060)    
Foreign currency translation adjustment 2,003             2,057   (54)
Accretion of tax equity financing fees (26)           (26)      
Contributions from NCI 2,997         0       2,997
Distributions to NCI (364)                 (364)
Net (loss) income 17,926           17,599     327
Ending balance (in shares) at Sep. 30, 2024       34,442,751 18,000,000          
Treasury stock, ending balance (in shares) at Sep. 30, 2024                 2,101,835  
Ending balance at Sep. 30, 2024 966,737     $ 3 $ 2 336,425 615,503 (2,803) $ (11,788) 29,395
Redeemable non-controlling interests, beginning balance at Dec. 31, 2024 2,463                  
Redeemable Non-controlling Interests (“RNCI”)                    
Accretion of tax equity financing fees 82                  
Net (loss) income (989)                  
Redeemable non-controlling interests, ending balance at Sep. 30, 2025 $ 1,556                  
Beginning balance (in shares) at Dec. 31, 2024   34,501,213 18,000,000 34,501,213 18,000,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2024 2,101,835               2,101,835  
Beginning balance at Dec. 31, 2024 $ 1,045,149     $ 3 $ 2 378,321 652,561 (5,874) $ (11,788) 31,924
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       89,178            
Exercise of stock options 662         662        
Stock-based compensation expense 10,341         10,341        
Employee stock purchase plan (in shares)       60,762            
Employee stock purchase plan 795         795        
Restricted stock units released (in shares)       101,202         0  
Unrealized loss from interest rate hedges, net (695)             (695)    
Foreign currency translation adjustment 5,594             5,502   92
Accretion of tax equity financing fees (82)           (82)      
Contributions from NCI 4,723         0       4,723
Distributions to NCI (5,343)                 (5,343)
Net (loss) income $ 32,742           25,914     6,828
Ending balance (in shares) at Sep. 30, 2025   34,752,355 18,000,000 34,752,355 18,000,000          
Treasury stock, ending balance (in shares) at Sep. 30, 2025 2,101,835               2,101,835  
Ending balance at Sep. 30, 2025 $ 1,093,886     $ 3 $ 2 390,119 678,393 (1,067) $ (11,788) 38,224
Redeemable non-controlling interests, beginning balance at Jun. 30, 2025 1,543                  
Redeemable Non-controlling Interests (“RNCI”)                    
Accretion of tax equity financing fees 27                  
Net (loss) income (14)                  
Redeemable non-controlling interests, ending balance at Sep. 30, 2025 1,556                  
Beginning balance (in shares) at Jun. 30, 2025       34,703,659 18,000,000          
Treasury stock, beginning balance (in shares) at Jun. 30, 2025                 2,101,835  
Beginning balance at Jun. 30, 2025 1,070,871     $ 3 $ 2 386,214 659,888 240 $ (11,788) 36,312
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       9,000            
Exercise of stock options 159         159        
Stock-based compensation expense 3,746         3,746        
Restricted stock units released (in shares)       39,696            
Unrealized loss from interest rate hedges, net (65)             (65)    
Foreign currency translation adjustment (1,085)             (1,242)   157
Accretion of tax equity financing fees (27)           (27)      
Contributions from NCI 924                 924
Distributions to NCI (2,491)                 (2,491)
Net (loss) income $ 21,854           18,532     3,322
Ending balance (in shares) at Sep. 30, 2025   34,752,355 18,000,000 34,752,355 18,000,000          
Treasury stock, ending balance (in shares) at Sep. 30, 2025 2,101,835               2,101,835  
Ending balance at Sep. 30, 2025 $ 1,093,886     $ 3 $ 2 $ 390,119 $ 678,393 $ (1,067) $ (11,788) $ 38,224